XBiotech Statistics Share Statistics XBiotech has 30.49M
shares outstanding. The number of shares has increased by 0.08%
in one year.
Shares Outstanding 30.49M Shares Change (YoY) 0.08% Shares Change (QoQ) 0% Owned by Institutions (%) 14.69% Shares Floating 19.5M Failed to Deliver (FTD) Shares 350 FTD / Avg. Volume 0.39%
Short Selling Information The latest short interest is 516.13K, so 1.69% of the outstanding
shares have been sold short.
Short Interest 516.13K Short % of Shares Out 1.69% Short % of Float 2.67% Short Ratio (days to cover) 13.26
Valuation Ratios The PE ratio is -3.12 and the forward
PE ratio is null.
XBiotech's PEG ratio is
-0.06.
PE Ratio -3.12 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.66 P/FCF Ratio -3.73 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for XBiotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.56,
with a Debt / Equity ratio of 0.06.
Current Ratio 11.56 Quick Ratio 11.56 Debt / Equity 0.06 Debt / EBITDA -0.28 Debt / FCF -0.32 Interest Coverage -52.63
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-418.82K Employee Count 92 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -32K Effective Tax Rate 0.08%
Stock Price Statistics The stock price has increased by -55.05% in the
last 52 weeks. The beta is 0.96, so XBiotech's
price volatility has been higher than the market average.
Beta 0.96 52-Week Price Change -55.05% 50-Day Moving Average 2.88 200-Day Moving Average 4.02 Relative Strength Index (RSI) 50.92 Average Volume (20 Days) 88,743
Income Statement
Revenue n/a Gross Profit n/a Operating Income -42.47M Net Income -38.53M EBITDA -36.01M EBIT -39.37M Earnings Per Share (EPS) -1.26
Full Income Statement Balance Sheet The company has 172.68M in cash and 10.25M in
debt, giving a net cash position of 162.43M.
Cash & Cash Equivalents 172.68M Total Debt 10.25M Net Cash 162.43M Retained Earnings -90.84M Total Assets 181.86M Working Capital 152.28M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -30.96M
and capital expenditures -1.3M, giving a free cash flow of -32.27M.
Operating Cash Flow -30.96M Capital Expenditures -1.3M Free Cash Flow -32.27M FCF Per Share -1.06
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
